Delivery Order SPE2DB22D3016-SPE2DB25FBJT7
- Not listed
- The Defense Logistics Agency awarded a $11,054.82 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for 500 tablets of Ondansetron HCl 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 4,...
- The Defense Logistics Agency awarded a $18,664.07 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count units) with a completion date of September 11, 2025. This competitive award, issued as a firm fixed-price delivery order with no set-aside designation, represents a single transaction under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Ondansetron ODT 4 mg, a commonly used anti-nausea medication, under a firm fixed-price contract valued at $1,842.70. The contract, which became effective on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded...
- The Defense Logistics Agency awarded a $15,645.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30 count) on September 15, 2025, with completion expected by September 16, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,836.91 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and federal healthcare settings. This firm fixed-price delivery order, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's Corporate Office location...
- The Defense Logistics Agency awarded a $17,056.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count units), with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside contract was issued on September 15, 2025, with performance to take place at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,525.13 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on September 11, 2025, with a completion date of September 12, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $27,231.46 to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in medical settings. This firm fixed-price delivery order was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.52 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by August 4, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, a pharmaceutical commonly used for nausea and vomiting management. This firm fixed-price delivery order, valued at $25,070.87, was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJT7Delivery Order
The Defense Logistics Agency awarded a $43,196.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCl 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. This non-set-aside contract, awarded on September 17, 2025, is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant position within the federal pharmaceutical supply chain through its comprehensive IDC with the Defense Logistics Agency. The company's contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Ondansetron HCl tablets exemplifies the routine pharmaceutical procurement operations conducted under the broader Prime Vendor Global Program framework, which supplies critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.2k | 9/17/25 |